Stefan Glück
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 70
- HER2/EGFR in Cancer Research 49
- Neutropenia and Cancer Infections 12
- Cancer Research top 2%
- Breast Cancer Treatment Studies 61
- Cancer Genomics and Diagnostics 15
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 15
-
- Advanced Breast Cancer Therapies 35
- Genetics top 5%
- Estrogen and related hormone effects 14
- Co-authors
- Alberto J. MonteroMichael H. AntoniSuzanne C. LechnerCharles S. CarverSoley BayraktarBonnie B. BlombergMuaiad KittanehRachel Syme
- Cited by
- OncologyCancer ResearchHematology
- Journals
- Journal of Clinical Oncology (18 papers)Breast Cancer Research and Treatment (15 papers)Bone Marrow Transplantation (12 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Stefan Glück
192 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 152
- Oncology 3.2k
- Cancer Research 1.0k
- Hematology 546
- Pulmonary and Respiratory Medicine 1.1k
- Genetics 302
Countries citing papers authored by Stefan Glück
This map shows the geographic impact of Stefan Glück's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Glück with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Glück more than expected).
Fields of papers citing papers by Stefan Glück
This network shows the impact of papers produced by Stefan Glück. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Glück. The network helps show where Stefan Glück may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefan Glück, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis | 2018 | 2 |
| 2 | 2016 | 19 | |
| 3 | 2014 | 14 | |
| 4 | 2011 | 51 | |
| 5 | Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary? | 2008 | 5 |
| 6 | 2008 | 9 | |
| 7 | 2004 | 18 | |
| 8 | 2003 | 10 | |
| 9 | 2002 | 220 | |
| 10 | 2001 | 17 | |
| 11 | 2001 | 9 | |
| 12 | 2001 | 24 | |
| 13 | 2001 | 6 | |
| 14 | 2000 | 51 | |
| 15 | 1999 | 23 | |
| 16 | 1998 | 92 | |
| 17 | 1997 | 35 | |
| 18 | 1996 | 11 | |
| 19 | 1996 | 1 | |
| 20 | 1996 | 6 |
About Stefan Glück
Stefan Glück is a scholar working on Oncology, Cancer Research, Hematology, Pulmonary and Respiratory Medicine and Immunology, having authored 199 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (70 papers), Breast Cancer Treatment Studies (61 papers), HER2/EGFR in Cancer Research (49 papers), Advanced Breast Cancer Therapies (35 papers), Cancer Genomics and Diagnostics (15 papers), Hematopoietic Stem Cell Transplantation (15 papers), Estrogen and related hormone effects (14 papers) and Neutropenia and Cancer Infections (12 papers). The work is most often cited by research in Oncology (3.2k citations), Cancer Research (1.0k citations), Hematology (546 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Genetics (302 citations). Stefan Glück has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Alberto J. Montero, Michael H. Antoni, Suzanne C. Lechner, Charles S. Carver, Soley Bayraktar, Bonnie B. Blomberg, Muaiad Kittaneh, Rachel Syme, Eli Avisar and Kristin Phillips. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Bone Marrow Transplantation, Cancer Research and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.